[Press release] New insights into Glioblastoma invasiveness
Researchers from the NORLUX Neuro-Oncology Laboratory at the LIH Department of Oncology (DONC) explored the molecular mechanisms responsible for the ability of Glioblastoma (GBM) to infiltrate and spread to healthy brain tissue. They brought forward the novel role of protein ZFAND3 in promoting the transcription of several genes that stimulate the invasion of GBM cells in the surrounding parenchyma, the functional tissue in the brain. The findings, which carry significant implications for the development of novel therapeutic strategies against GBM, were published in the international journal Nature Communications.
Cross-border collaborations to improve cancer treatment
On December 9th, Medical & Bio Decision (MBD) announced the setup of a joint laboratory for precision medicine tailored to cancer patients, in collaboration with the Luxembourg Institute of Health (LIH) and the Integrated Biobank of Luxembourg (IBBL).
[Press release] Luxembourg researchers receive prestigious international award
Dr Andy Chevigné and Dr Martyna Szpakowska from the LIH Department of Infection and Immunity (DII) were rewarded for their outstanding contribution to molecular pharmacology during a virtual ceremony on Tuesday, December 8th, in the presence of Frank Vandenbroucke, Belgian Minister of Public Health and Social Affairs, and of representatives of pharmaceutical companies and healthcare hubs. The Galien Prize is traditionally organised in Belgium and Luxembourg by Roularta HealthCare on a yearly basis and crowns the most significant discoveries in the fields of pharmacology, drug development and medical devices.
17 December 2020 03:00 PM
WEBINAR: Lecture series Cancer Research: "Die or live trying - Cellular agony in anticancer immunity" - Prof Lorenzo Galluzzi
Med.Doctor-PhD position in Pediatric Food Allergy Research (medical background) - AK1220
i2TRON is a highly innovative PhD training program on “integrating immune strategies for Translational Research in Oncology and Neurology” and is supported by the Luxembourg National Research Fund (FNR) within their PRIDE program. We will develop the next generation of translational scientists as boundary crossers, domain experts and skilled communicators. Inflammation is a common hallmark shared across different non-communicable diseases (NCD).
Biostatistician - Clinical trials - MV1220
The Biostatistician will join the LIH’s CompetenceCenter for Methodology and Statistics (CCMS). Within the clinical research hub of theDepartment of Population Health, the CCMS provides methodological support instatistical planning, analysis & data handling for various laboratories andresearch groups. It also offers training in statistics as well as support inwriting papers.
03 December 2020 11:00 AM
WEBINAR: Lecture series Cancer Research: "Epigenetic signaling circuits in the tumor microenvironment that modulate invasion and metastasis" - Prof Douglas Hanahan
Solidarity in COVID-19 times
On Thursday, November 26th 2020, the Luxembourg Institute of Health (LIH) had the pleasure of welcoming the Director of the André Losch Foundation to its premises in Strassen for a visit of its Clinical and Epidemiological Investigation Centre (CIEC). The event also provided an opportunity to discuss the status of the COVID-19 projects coordinated by LIH and supported by the Foundation.
Research Strategy Specialist - Research Programmes in Infection and Immunity - MO1120
The Research Strategy Specialist will report to, and work in close partnership with the Director of the Department of Infection and Immunity, supporting and complementing the work of the LIH to deliver excellence in fundamental and biomedical research programmes in Luxembourg. Research at the Department of Infection and Immunity aims to understand the complex immune mechanisms of infections and inflammatory disease processes and cancer, enabling new ways to diagnose and prevent or cure human diseases caused by these disorders.